Moderna to Present at the Goldman Sachs 13th Annual Healthcare CEOs Unscripted Conference: A View from the Top

Rhea-AI Summary

Moderna (Nasdaq: MRNA) announced CEO Stéphane Bancel's virtual participation in the Goldman Sachs 13th Annual Healthcare CEOs Unscripted Conference on January 5, 2021, at 8:00 a.m. ET. A live webcast will be accessible in the Investors section on the Moderna website, with a replay available for 90 days post-event. Moderna is pioneering mRNA science to create transformative medicines, addressing various diseases through a robust pipeline of therapeutics and vaccines, in collaboration with strategic partners like AstraZeneca and Merck.

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Stéphane Bancel, Chief Executive Officer, will participate virtually in the Goldman Sachs 13^th Annual Healthcare CEOs Unscripted Conference on January 5^th, 2021 at 8:00 a.m. ET.

A live webcast will be available under “Events and Presentations” in the Investors section of the Moderna website at investors.modernatx.com. A replay of the webcast will be archived on Moderna’s website for 90 days following the presentation.

About Moderna

Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that can have a therapeutic or preventive benefit and have the potential to address a broad spectrum of diseases. The company’s platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, providing Moderna the capability to pursue in parallel a robust pipeline of new development candidates. Moderna is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune and inflammatory diseases, independently and with strategic collaborators.

Headquartered in Cambridge, Mass., Moderna currently has strategic alliances for development programs with AstraZeneca PLC and Merck & Co., Inc., as well as the Defense Advanced Research Projects Agency (DARPA), an agency of the U.S. Department of Defense, and BARDA. Moderna has been named a top biopharmaceutical employer by Science for the past six years. To learn more, visit www.modernatx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201229005053/en/

FAQ

What event will Moderna's CEO attend on January 5, 2021?

Moderna's CEO Stéphane Bancel will participate in the Goldman Sachs 13th Annual Healthcare CEOs Unscripted Conference.

Where can I watch the webcast of Moderna's CEO presentation?

The webcast can be viewed in the 'Events and Presentations' section of the Moderna Investors website.

How long will the webcast replay be available after the conference?

The replay of the webcast will be archived for 90 days following the presentation.

What is Moderna's focus in its research and development?

Moderna focuses on developing mRNA therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and more.

Who are Moderna's strategic collaborators?

Moderna collaborates with AstraZeneca, Merck, DARPA, and BARDA on various development programs.